Dnae Oncology Limited
09758933
Some Concerns
- Negative net worth (-10)
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 01/09/2025
Due 15/09/2026
Industry
Officers
director · Since 02/09/2015
PRESIDENT, COO AND EXECUTIVE DIRECTOR
MALAYSIAN · MALAYSIA · Age 61
Also on 2 other boards
director · Since 02/09/2015
PROFESSOR
BRITISH · UNITED KINGDOM · Age 64
Also on 4 other boards
Persons with Significant Control
Dnae Group Holdings Limited
56, Wood Lane, London, W12 7SB
Reg: 4821572 · England And Wales · Company Limited By Shares
Notified 06/04/2016
CompanyRankvs 3088+ SIC 72110 peers31
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Turnover
£0
Annual revenue
Net Worth
-£5.9M
Balance sheet strength
Cash
£0
Cash in the bank
Profit Before Tax
-£215k
Bottom line earnings
Net Current Assets
-£5.9M
Working capital
Current Assets
£0
Current Liabilities
£5.9M
Fixed Assets
£0
Debtors
£0
Cost of Sales
£0
Gross Profit
£0
Admin Expenses
£0
Operating Profit
£0
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 0.00 |
Derived from filed accounts. Not audited figures.